MedPath

Lipitor

These highlights do not include all the information needed to use LIPITOR safely and effectively. See full prescribing information for LIPITOR. LIPITOR (atorvastatin calcium) Tablets for oral administration Initial U.S. Approval: 1996

Approved
Approval ID

a3c08a6d-f986-4efc-9f96-3f0e652704dc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

atorvastatin calcium

PRODUCT DETAILS

NDC Product Code21695-255
Application NumberNDA020702
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateFebruary 23, 2010
Generic Nameatorvastatin calcium

INGREDIENTS (13)

calcium carbonateInactive
Code: H0G9379FGK
Classification: IACT
hydroxypropyl celluloseInactive
Code: RFW2ET671P
Classification: IACT
atorvastatin calciumActive
Quantity: 40 mg in 1 1
Code: 48A5M73Z4Q
Classification: ACTIM
lactose monohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
polyethylene glycolInactive
Code: 3WJQ0SDW1A
Classification: IACT
croscarmellose sodiumInactive
Code: M28OL1HH48
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT
candelilla waxInactive
Code: WL0328HX19
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
talcInactive
Code: 7SEV7J4R1U
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8H
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lipitor - FDA Drug Approval Details